{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:57:47Z","timestamp":1761512267958},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.semarthrit.2006.04.001","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T22:52:09Z","timestamp":1152226329000},"page":"10-21","source":"Crossref","is-referenced-by-count":14,"title":["The Effects of Antifracture Therapies on the Components of Bone Strength: Assessment of Fracture Risk Today and in the Future"],"prefix":"10.1016","volume":"36","author":[{"given":"K. Shawn","family":"Davison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Siminoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goltzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony B.","family":"Hodsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Josse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech P.","family":"Olszynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis-George","family":"Ste-Marie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Kendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Tenenhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques P.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2006.04.001_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S8756-3282(97)00170-1","article-title":"Bone mineral density reflects bone mass but also the degree of mineralization of bone","volume":"21","author":"Meunier","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(00)00448-8","article-title":"Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34)","volume":"28","author":"Kneissel","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S8756-3282(99)00165-9","article-title":"Complementary information on bone ultrastructure from scanning small angle X-ray scattering and Fourier-transform infrared microspectroscopy","volume":"25","author":"Camacho","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S8756-3282(01)00485-9","article-title":"Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women","volume":"29","author":"Roschger","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1445-5994.1983.tb04658.x","article-title":"Pathologic fracture due to severe osteomalacia following low-dose diphosphonate treatment of Paget\u2019s disease of bone","volume":"13","author":"Evans","year":"1983","journal-title":"Aust NZ J Med"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S8756-3282(00)00284-2","article-title":"Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation?","volume":"27","author":"Hirano","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib7","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1359\/jbmr.2002.17.8.1372","article-title":"Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens","volume":"17","author":"Nuzzo","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib9","first-page":"538","article-title":"Effects of bisphosphonates on matrix mineralization","volume":"2","author":"Boivin","year":"2002","journal-title":"J Musculoskel Neuron Interact"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S8756-3282(02)00973-0","article-title":"Constant mineralization density distribution in cancellous human bone","volume":"32","author":"Roschger","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S8756-3282(02)00869-4","article-title":"Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis","volume":"31","author":"Eriksen","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib12","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib13","first-page":"202","article-title":"3-D synchrotron micro-CT allows unique insight of changes in bone quality with risedronate therapy","volume":"72","author":"Ritman","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib14","first-page":"S308","article-title":"Five year risedronate therapy normalizes mineralization","volume":"19","author":"Borah","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib15","first-page":"S261","article-title":"Effects of intravenous zoledronic acid on the degree of mineralization of bone in postmenopausal osteoporosis","volume":"18","author":"Boivin","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib16","first-page":"S284","article-title":"Effects of intravenous zoledronic acid on bone remodeling in postmenopausal osteoporosis","volume":"16","author":"Arlot","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib17","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1210\/jc.2002-022020","article-title":"Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women","volume":"88","author":"Boivin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib18","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","article-title":"Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis","volume":"88","author":"Misof","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib19","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1007\/s00198-003-1468-2","article-title":"Bone mineral crystal size","volume":"14","author":"Boskey","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s002239900522","article-title":"The effect of fluoride on the size and morphology of apatite crystals grown from physiologic solutions","volume":"63","author":"Eanes","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/8756-3282(94)90815-X","article-title":"Marked decrease in trabecular bone quality after five years of sodium fluoride therapy\u2014assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients","volume":"15","author":"Sogaard","year":"1994","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1359\/jbmr.2003.18.6.955","article-title":"Effect of hormone replacement therapy on bone quality in early postmenopausal women","volume":"18","author":"Paschalis","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib24","first-page":"212","article-title":"Three-years treatment with risedronate preserves bone quality","volume":"72","author":"Paschalis","year":"2003","journal-title":"Calcif Tissue Int"},{"issue":"suppl 3","key":"10.1016\/j.semarthrit.2006.04.001_bib25","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/s00198-002-1347-2","article-title":"The mineralization of bone tissue","volume":"14","author":"Boivin","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002230001204","article-title":"Response of cortical bone to antiresorptive treatment","volume":"68","author":"Hyldstrup","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00223-002-2104-4","article-title":"Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography","volume":"73","author":"Dufresne","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/jbmr.5650100710","article-title":"Growth hormone stimulates bone formation and strength of cortical bone in aged rats","volume":"10","author":"Andreassen","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/8756-3282(91)90022-B","article-title":"Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone","volume":"12","author":"Jorgensen","year":"1991","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF03549782","article-title":"Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum","volume":"53","author":"Oxlund","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S8756-3282(97)00271-8","article-title":"Early effects of short-term parathyroid hormone administration on bone mass, mineral content, and strength in female rats","volume":"22","author":"Toromanoff","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1359\/JBMR.040112","article-title":"Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity","volume":"19","author":"Sato","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib34","first-page":"198","article-title":"How drugs decrease fracture risk","volume":"2","author":"Cummings","year":"2002","journal-title":"J Musculoskel Neuron Interact"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib35","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bone.2003.12.013","article-title":"Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography","volume":"34","author":"Borah","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib36","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","article-title":"Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis","volume":"16","author":"Dempster","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib37","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles","volume":"28","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S8756-3282(98)00103-3","article-title":"Influence of microdamage on fracture toughness of the human femur and tibia","volume":"23","author":"Norman","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib41","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S8756-3282(97)00200-7","article-title":"Trabecular bone volume and microdamage accumulation in the femoral heads of women with and without femoral neck fractures","volume":"21","author":"Mori","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0221-8747(81)90045-X","article-title":"The long-term skeletal effects of EHDP in dogs","volume":"3","author":"Flora","year":"1981","journal-title":"Metab Bone Dis Relat Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jor.1100030413","article-title":"Effect of EHDP on fracture healing in dogs","volume":"3","author":"Lenehan","year":"1985","journal-title":"J Orthop Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib46","first-page":"186","article-title":"Review of fracture experience during treatment of Paget\u2019s disease of bone with etidronate disodium (EHDP)","author":"Johnston","year":"1983","journal-title":"Clin Orthop"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib47","first-page":"150","article-title":"Spontaneous fractures of uninvolved bones in patients with Paget\u2019s disease during unduly prolonged treatment with disodium etidronate (EHDP)","author":"Mautalen","year":"1986","journal-title":"Clin Orthop"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib48","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.292.6530.1227","article-title":"Osteomalacia in Paget\u2019s disease treated with short term, high dose sodium etidronate","volume":"292","author":"Gibbs","year":"1986","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s002230010036","article-title":"Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage","volume":"69","author":"Li","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1185\/030079903125003125","article-title":"Efficacy of risedronate on clinical vertebral fractures within six months","volume":"20","author":"Roux","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","article-title":"Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs","volume":"112","author":"Cummings","year":"2002","journal-title":"Am J Med"},{"issue":"8381","key":"10.1016\/j.semarthrit.2006.04.001_bib52","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(84)92272-4","article-title":"Focal osteomalacia due to low-dose diphosphonate therapy in Paget\u2019s disease","volume":"1","author":"Boyce","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1359\/jbmr.2001.16.1.157","article-title":"Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys","volume":"16","author":"Burr","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00223-001-2048-0","article-title":"The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography","volume":"70","author":"Boivin","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib55","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1359\/jbmr.2002.17.12.2222","article-title":"Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry","volume":"17","author":"Miller","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib57","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib58","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib59","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"A multinational, placebo-controlled, randomized study of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass","volume":"9","author":"Pols","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib60","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/jc.2002-020400","article-title":"Risedronate prevents new vertebral fractures in postmenopausal women at high risk","volume":"88","author":"Watts","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib61","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib62","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/er.2001-4002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal. osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib63","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/er.2001-3002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib64","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene","volume":"282","author":"Ettinger","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/JCD:7:3:255","article-title":"Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate","volume":"7","author":"Watts","year":"2004","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib67","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s001980170020","article-title":"Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis","volume":"12","author":"Bjarnason","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1359\/jbmr.2002.17.1.1","article-title":"Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy","volume":"17","author":"Sarkar","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib69","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJM199003223221203","article-title":"Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis","volume":"322","author":"Riggs","year":"1990","journal-title":"N Eng J Med"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib70","first-page":"268","article-title":"Bone fragility of the peripheral skeleton during fluoride therapy for osteoporosis","author":"Schnitzler","year":"1990","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s001980050041","article-title":"Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis","volume":"8","author":"Meunier","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib72","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00006254-200407000-00021","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"59","author":"Meunier","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib73","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib74","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1172\/JCI113523","article-title":"Age and bone mass as predictors of fracture in a prospective study","volume":"81","author":"Hui","year":"1988","journal-title":"J Clin Invest"},{"issue":"suppl 6","key":"10.1016\/j.semarthrit.2006.04.001_bib75","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","article-title":"The use of biochemical markers of bone turnover in osteoporosis","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos Int"},{"issue":"suppl 6","key":"10.1016\/j.semarthrit.2006.04.001_bib76","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s001980070006","article-title":"Markers of bone turnover for the prediction of fracture risk","volume":"11","author":"Garnero","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib77","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s001980070088","article-title":"Clinical use of biochemical markers of bone remodeling","volume":"11","author":"Looker","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib78","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","article-title":"Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate","volume":"18","author":"Eastell","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib79","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1359\/JBMR.0301231","article-title":"Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate","volume":"19","author":"Seibel","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib80","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bone.2003.10.004","article-title":"Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk","volume":"34","author":"Reginster","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib81","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1359\/jbmr.2003.18.10.1789","article-title":"Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use","volume":"18","author":"Garnero","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib82","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s001980050100","article-title":"Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women?","volume":"8","author":"Garnero","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib83","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S8756-3282(01)00653-6","article-title":"Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies","volume":"30","author":"Kanis","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib84","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S8756-3282(03)00236-9","article-title":"Is the paradigm shifting?","volume":"33","author":"Heaney","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib85","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-114-11-919","article-title":"Pre-existing fractures and bone mass predict vertebral fracture incidence in women","volume":"114","author":"Ross","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib86","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib87","first-page":"S1734","article-title":"2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib88","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib89","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00198-004-1709-z","article-title":"Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures","volume":"16","author":"Siminoski","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib90","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1359\/jbmr.2002.17.12.2265","article-title":"Quantitative magnetic resonance imaging in the calcaneus and femur of women with varying degrees of osteopenia and vertebral deformity status","volume":"17","author":"Wehrli","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2006.04.001_bib91","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00330-002-1695-5","article-title":"High-resolution MRI vs multislice spiral CT","volume":"13","author":"Link","year":"2003","journal-title":"Eur Radiol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017206000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017206000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T08:44:42Z","timestamp":1627548282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017206000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0049017206000503"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2006.04.001","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}